Sophia Genetics is an artificial Intelligence based tech company that combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing.
SOPHiA GENETICS offers genomic and radiomic analysis to hospitals. The company uses its AI-based technology to analyze genomic profiles produced by next-generation DNA Sequencing and unearth actionable insights. Processing medical images, the application also leverages radiomics to predict and monitor the evolution of tumors.
SOPHiA GENETICS was co-founded by Jurgi Camblong, Pierre Hutter, and Lars Steinmetz in 2011. The company is based in Lausanne, Vaud, Switzerland and Boston, Massachusetts. Sophia Genetics also has an office in Bidart, France.
Sophia Genetics' mission is to bring data analytics solutions to market, to support healthcare professionals by maximizing the power of Data-Driven Medicine.
SOPHiA GENETICS' technology uses multiple sources of medical data to come up with potentially novel insights about how diseases spread in the body, and offer better ways to coordinate care. The company’s tech is currently used by more than 1,000 healthcare institutions and has analyzed 600,000 genomic profiles.
SOPHiA GENETICS is backed by Balderton Capital, Credit Suisse, Swisscom Ventures, Generation Investment Management, aMoon, Hitachi Ventures, Idinvest Partners, 360 Capital Partners and others. The company raised $110M in a new round on Oct 01, 2020. This brings Sophia's total funding to $250M to date. The company has also acquired Interactive Biosoftware on Jun 17, 2018.
SOPHiA GENETICS was ranked among the 50 smartest companies by the MIT Technology Review in 2017.